Tonix Pharmaceuticals Holding Corp. (TNXP) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 132.95M |
| Enterprise Value | -73.38M |
| P/E Ratio | -0.31 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 1.54 |
| Price/Book Ratio | 0.36 |
| Enterprise/Revenue | 1.54 |
| Enterprise/EBITDA | -0.37 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -4.2 |
| Operating Margin | -4.36 |
| Return On Assets | -746.56 |
| Return On Equity | -0.81 |
| Revenue | 13.11M |
| Revenue/Share | 2.33 |
| Gross Profit | 4.54M |
| EBITDA | -122.01M |
| Net Income | -124.02M |
| Diluted EPS | -14.57 |
| Total Cash | 162,793 |
| Total Cash/Share | 0.01 |
| Total Debt | 1,253 |
| Total Debt/Equity | 0 |
| Current Ratio | 4.57 |
| Book Value Per Share | 0.01 |
| 52-Week Change | -77.92 |
| 52-Week High | 20.56 |
| 52-Week Low | 3.82 |
| Moving Average 50 Days | 8.33 |
| Moving Average 200 Days | 12.02 |
| Average Volume | 691,767 |
| Shares Outstanding | 17.15M |
| % Held by Institutions | 68.7 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:100 |
| Last Split Date | February 05, 2025 |